Thelin Approval Status 
- FDA approved: No
- Brand name: Thelin
- Generic name: sitaxsentan
- Company: Encysive Pharmaceuticals
- Treatment for: Pulmonary Arterial Hypertension (PAH)
Thelin is an endothelin receptor antagonist currently being evaluated by the FDA as a potential new oral treatment for patients with pulmonary arterial hypertension (PAH).
FDA Approval Status for Thelin
| Date | Article |
|---|
| Sep 6, 2007 | Encysive Pharmaceuticals Receives Written Response From FDA On Its
Request for Formal Dispute Resolution for Thelin (Sitaxsentan
Sodium) |
| Aug 7, 2007 | Encysive Pharmaceuticals Files Request for Formal Dispute
Resolution With U.S. FDA to Contest Third Approvable Letter for Thelin |
| Jul 13, 2007 | Encysive Pharmaceuticals Provides Update for Thelin (Sitaxsentan
Sodium) |
| Jun 18, 2007 | FDA Issues Third Approvable Letter for Thelin (Sitaxsentan Sodium) |
| Dec 28, 2006 | FDA Accepts Encysive’s Complete Response to Thelin New Drug Application |
| Dec 15, 2006 | Encysive Pharmaceuticals Submits Response to FDA For Thelin New Drug Application |
| Dec 14, 2006 | Encysive Expects to Submit Revised Response to Thelin Approvable Letter Within Several Days |
| Nov 2, 2006 | Encysive Submits Complete Response to FDA For Thelin New Drug Application |
| Jul 24, 2006 | FDA Issues Approvable Letter for Thelin; One Outstanding Item Remains |
| Jun 15, 2006 | FDA Grants Class 1 Review to Encysive Pharmaceuticals’ Complete Response to Thelin NDA |
| May 25, 2006 | Encysive Pharmaceuticals Submits Complete Response to FDA for Thelin New Drug Application |
| Mar 24, 2006 | Encysive Pharmaceuticals Receives Approvable Letter From FDA for Thelin |
| Jul 14, 2005 | Encysive Announces PDUFA Date for Thelin New Drug Application in Pulmonary Arterial Hypertension |
| May 25, 2005 | Encysive Pharmaceuticals Submits New Drug Application for Thelin |
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
